BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35922373)

  • 21. Pleomorphic dermal sarcoma: Clinicopathological features and outcomes from a 5-year tertiary referral centre experience.
    Logan IT; Vroobel KM; le Grange F; Perrett CM
    Cancer Rep (Hoboken); 2022 Nov; 5(11):e1583. PubMed ID: 34766474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma: A meta-analysis of individualized participant data.
    Ørholt M; Aaberg FL; Abebe K; Walsh S; Roenigk RK; Venzo A; Schmidt G; Klyver H; Jensen DH; Herly M; Vester-Glowinski PV
    J Surg Oncol; 2022 Sep; 126(3):555-562. PubMed ID: 35441377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical fibroxanthoma and pleomorphic dermal sarcoma: A reappraisal.
    Cesinaro AM; Gallo G; Tramontozzi S; Migaldi M
    J Cutan Pathol; 2021 Feb; 48(2):207-210. PubMed ID: 32583897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spindle Cell/Pleomorphic Lipoma With Trichodiscoma-like Epithelial Hyperplasia Mimicking Atypical Fibroxanthoma/Pleomorphic Dermal Sarcoma.
    Aghighi M; Andea AA; Patel RM; Fullen DR; Bresler SC
    Am J Dermatopathol; 2022 Oct; 44(10):764-767. PubMed ID: 35503875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spindle Cell Atypical Fibroxanthoma: Myofibroblastic Differentiation Represents a Diagnostic Pitfall in This Variant of AFX.
    Harding-Jackson N; Sangueza M; Mackinnon A; Suster S; Plaza JA
    Am J Dermatopathol; 2015 Jul; 37(7):509-14; quiz 515-6. PubMed ID: 26098709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical fibroxanthoma, rare and often unrecognized cutaneous soft tissue tumor - a case report and review of the literature.
    Čierna Z; Trška R
    Cesk Patol; 2019; 55(3):182-186. PubMed ID: 31726845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
    Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
    Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pleomorphic Dermal Sarcoma With Metastasis to the Lung: A Case Report.
    Shafi S; Bechtel M; Contreras CM; Plaza JA
    Am J Dermatopathol; 2023 Oct; 45(10):708-711. PubMed ID: 37335842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clear cell atypical fibroxanthoma:a clinicopathologic study.
    Crowson AN; Carlson-Sweet K; Macinnis C; Taylor JR; Battaglia T; LaMar WL; Minor D; Sutter S; Hill T
    J Cutan Pathol; 2002 Jul; 29(6):374-81. PubMed ID: 12135470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clear Cell Atypical Fibroxanthoma: Clinicopathological Study of 6 Cases and Review of the Literature With Special Emphasis on the Differential Diagnosis.
    Tardío JC; Pinedo F; Aramburu JA; Martínez-González MÁ; Arias D; Khedaoui R; Suárez-Massa D; Santonja C
    Am J Dermatopathol; 2016 Aug; 38(8):586-92. PubMed ID: 26848640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
    Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
    Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation Between Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Histopathologic Features and Review of the Literature.
    Iglesias-Pena N; Martínez-Campayo N; López-Solache L
    Actas Dermosifiliogr (Engl Ed); 2021 May; 112(5):392-405. PubMed ID: 33301761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pleomorphic dermal sarcoma of the scalp: Review of management and distinguishing features from atypical fibroxanthoma.
    Cohen AJ; Talasila S; Lazarevic B; Gleason L; Patel V; Nikbakht N
    JAAD Case Rep; 2022 Nov; 29():123-126. PubMed ID: 36262359
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of pleomorphic dermal sarcoma with perineural invasion treated with Mohs micrographic surgery and adjuvant radiation therapy.
    Kurtti A; Farhadian J; Meehan S; Madu P; Bradu S
    Dermatol Online J; 2022 Jan; 28(1):. PubMed ID: 35499417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical fibroxanthoma with pseudoangiomatous features: a histological and immunohistochemical mimic of cutaneous angiosarcoma.
    Thum C; Husain EA; Mulholland K; Hornick JL; Brenn T
    Ann Diagn Pathol; 2013 Dec; 17(6):502-7. PubMed ID: 24080496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical excision margins for fibrohistiocytic tumors, including atypical fibroxanthoma and undifferentiated pleomorphic sarcoma: A probability model based on a systematic review.
    Jibbe A; Worley B; Miller CH; Alam M
    J Am Acad Dermatol; 2022 Oct; 87(4):833-840. PubMed ID: 34587553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myxoid atypical fibroxanthoma: a previously undescribed variant.
    Patton A; Page R; Googe PB; King R
    J Cutan Pathol; 2009 Nov; 36(11):1177-84. PubMed ID: 19320792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sarcoma-like tumor of head and neck skin.
    Nonaka D; Bishop PW
    Am J Surg Pathol; 2014 Jul; 38(7):956-65. PubMed ID: 24705313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clear cell atypical fibroxanthoma: a case report and review of the literature.
    Nguyen CM; Chong K; Cassarino D
    J Cutan Pathol; 2016 Jun; 43(6):538-542. PubMed ID: 26956561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical expression of melanocytic and myofibroblastic markers and their molecular correlation in atypical fibroxanthomas and pleomorphic dermal sarcomas.
    Helbig D; Mauch C; Buettner R; Quaas A
    J Cutan Pathol; 2018 Dec; 45(12):880-885. PubMed ID: 30155964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.